Clinical Trial Update: Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential Hypertension [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated the efficacy and safety of Azilsartan in adults with mild to moderate uncomplicated essential hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Azilsartan (azilsartan)

Snippet

Sponsor: Takeda | Conditions: Essential Hypertension | Phase 2 | Status: COMPLETED